z-logo
Premium
Factors related to allergic transfusion reactions and febrile non‐haemolytic transfusion reactions in children
Author(s) -
Yanagisawa R.,
Shimodaira S.,
Sakashita K.,
Hidaka Y.,
Kojima S.,
Nishijima F.,
Hidaka E.,
Shiohara M.,
Nakamura T.
Publication year - 2016
Publication title -
vox sanguinis
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.68
H-Index - 83
eISSN - 1423-0410
pISSN - 0042-9007
DOI - 10.1111/vox.12373
Subject(s) - medicine , platelet , population , fresh frozen plasma , adverse effect , blood transfusion , pediatrics , environmental health
Background and Objectives Allergic transfusion reactions ( ATR s) and febrile non‐haemolytic transfusion reactions ( FNHTR s) are the two major types of transfusion‐related adverse reactions ( TRAR s). Although prestorage leucocyte reduction and diversion of the first aliquot of blood ( LR / D ) could reduce FNHTR s and bacterial contamination in adult transfusion, ATR s are still problematic. In addition, there is little information about TRAR s in paediatric population. Materials and Methods We conducted a single‐centre retrospective analysis of all transfusions, except washing products, and TRAR s for 153 months to evaluate related factors such as delivery of treatment and the characteristics of recipients. Results Most TRAR s were FNHTR s and/or ATR s in children. In delivering blood products with LR /D, the frequencies of not only FNHTR s but also ATR s were significantly reduced with both platelet concentrates ( PC s) and red cell concentrates ( RCC s). TRAR s of fresh‐frozen plasma were infrequent in children. In addition, even after the introduction of LR /D, ATR s were significantly more frequent in patients with primary haematological and malignant diseases who received PC s and RCC s, older patients who received PC s and patients who received frequent RCC s. Conclusion These results suggest that leucocytes or mediators from leucocytes are underlying cause of ATR s in addition to FNHTR s in children. Furthermore, particular characteristics of patients would be other risk factors for ATR s.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom